VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
Illustration for: Jersey Mike's Raises $1B in Blackstone-Backed NYSE Debut
Value Add VC/Pulse/IPO$1B IPO

Jersey Mike's Raises $1B in Blackstone-Backed NYSE Debut

Jersey Mike's began trading on the NYSE under ticker JMKE after pricing its IPO at $23 a share, raising roughly $1 billion and valuing the sandwich chain at $7.3 billion, though shares opened below the IPO price as Blackstone retains majority voting control.

$23/share
IPO price
~$1B
Raised
$7.3B
Valuation
~-2%
Day-1 move
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 30, 2026
2 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Jersey Mike's priced its IPO at $23 per share, the top of its range, selling 43.5 million Class A shares to raise approximately $1 billion and value the company at $7.3 billion, before opening at $21 and trading down roughly 2% on its first day

2

Blackstone, which acquired majority control of Jersey Mike's for roughly $8 billion including debt, will retain control of approximately two-thirds of the company's shareholder votes after the IPO through a dual-class share structure

3

The offering included a 30-day underwriter option to purchase up to 6.5 million additional shares to cover over-allotments, a standard IPO mechanism that can modestly increase total proceeds if exercised

4

The debut lands alongside Reformation's flat NYSE opening the same week, giving investors two consumer-brand IPOs to compare in a market that has shown considerably more enthusiasm for AI-adjacent and biotech listings than consumer names this earnings season

TC

The VC Read · Trace's Take

Trace Cohen

A dual-class structure that hands public investors two-thirds less voting power than their capital contribution is exactly the kind of detail that gets buried in the excitement of a $1 billion raise and then resurfaces as a governance fight three years later. The flat-to-down reception for both Jersey Mike's and Reformation this week versus Apnimed's 37% pop is the market drawing a clean line: growth and differentiation get rewarded, mature consumer brands with sponsor control don't, no matter how recognizable the name.

Tech IPO Tracker →

Analysis

Jersey Mike's began trading on the New York Stock Exchange under ticker JMKE on Thursday after pricing its IPO at $23 per share, the top of its marketed range, raising approximately $1 billion and valuing the sandwich chain at $7.3 billion. Shares nonetheless opened below the IPO price at $21 and traded down roughly 2% through the session, a soft debut for one of the year's more closely watched consumer listings.

The offering comprised 43.5 million shares of Class A common stock, with underwriters holding a 30-day option to purchase up to an additional 6.5 million shares to cover over-allotments if demand warrants. Blackstone, which had acquired majority control of Jersey Mike's for roughly $8 billion including debt in a prior transaction, retains control of approximately two-thirds of the company's shareholder votes through a dual-class structure -- meaning public investors are buying meaningful economic exposure without commensurate governance influence.

The soft opening fits a broader pattern this week: Reformation, the Permira-backed womenswear retailer, also opened flat in its own NYSE debut the same day, giving the market two consumer-brand IPOs to compare directly. Both landed considerably cooler than Apnimed's 37% pop in its Nasdaq debut a day later, reinforcing that 2026's IPO window is rewarding biotech and differentiated growth stories more generously than mature consumer brands, however strong their underlying unit economics.

Jersey Mike's brings real scale to the public markets -- a nationally recognized sandwich chain with an established franchise model -- but investors appear to be pricing in the same private-equity-exit dynamic that has weighed on other sponsor-backed consumer IPOs this year: strong brand recognition doesn't automatically translate into the growth multiple public markets reward, particularly when a financial sponsor retains outsized voting control post-listing.

For franchise and consumer-brand investors, the debut is a useful data point on where the market's appetite currently sits: real, profitable, well-known consumer businesses are getting priced for what they are rather than commanding growth-stock multiples, a discipline that has been notably absent in AI-adjacent listings this year. What to watch: whether Jersey Mike's stock stabilizes above its IPO price in coming weeks, and whether Blackstone's retained control becomes a point of tension with public shareholders over capital allocation decisions.

ShareXLinkedInEmail

Analysis and editorial commentary by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Jul 31, 2026

Apnimed Soars 37% in Nasdaq Debut for Sleep Apnea Pill

Illustration for: Apnimed Soars 37% in Nasdaq Debut for Sleep Apnea Pill
IPO$192M IPO

Apnimed Soars 37% in Nasdaq Debut for Sleep Apnea Pill

Apnimed shares jumped as much as 37.5% in their Nasdaq debut after the Phase 3 biotech priced its upsized IPO at $16 a share, raising $192 million to fund what could become the first FDA-approved pill for obstructive sleep apnea.

IPO· Jul 31, 2026

Eric Trump-Backed Space-Eyes to Go Public in $638M SPAC Deal

Illustration for: Eric Trump-Backed Space-Eyes to Go Public in $638M SPAC Deal
IPO$638M SPAC merger

Eric Trump-Backed Space-Eyes to Go Public in $638M SPAC Deal

Space-Eyes, a counter-drone and geospatial intelligence company backed by Eric Trump, agreed to go public through a merger with McKinley Acquisition Corp valuing the combined business at $638 million, with the combined company expected to list as CUAS.

IPO· Jul 31, 2026

East West Ave Prices $100M SPAC IPO on Nasdaq

Illustration for: East West Ave Prices $100M SPAC IPO on Nasdaq
IPO$100M SPAC IPO

East West Ave Prices $100M SPAC IPO on Nasdaq

East West Ave Acquisition Corp priced a $100 million IPO of 10 million units at $10 each, targeting fintech, digital assets and energy deal opportunities as blank-check listings continue picking up in 2026.

@Trace_Cohen·t@nyvp.com